Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Mondobiotech Holding AG Basel (RLFTF) Message Board

$RLFTF (related) thread on Yh-0 by Glunker I di

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 653
(Total Views: 302)
Posted On: 04/30/2021 6:17:26 AM
Avatar
Posted By: mc67
$RLFTF (related) thread on Yh-0 by Glunker

I did my own statistical analysis of the data provided in the Previous SSRN Peer Review report. Z-test of Proportions on the various values provided in Table 4 - Day 60 Mortality by Site of Care.

I notice that they never showed a statistic for the total number of Aviptadil vs Placebo patients and deaths across both Tertiary and Regional hospitals (Aviptadil 136 patients, 46 deaths [35.1%] / Placebo 65 patients, 37 deaths [56.9%]).

I ran the statistic for this and got a P-value of 0.00181. However, there is a difference in the actual totals shown in the Placebo Deaths column for Tertiary (23 vs 30 [true sum]) with asterisks noting it.

If you put the seeming 'incorrect' sum value of 23 in the results, the percent deaths is the reported value of 46.2%, and the P-value comes out to be 0.067...just off the mark of 0.05...so it wasn't reported as significant.

7 patients were pulled from the placebo death column for the tertiary hospitals as indicated by an asterisk note in the table.


The result with asterisks are not explicitly discussed in the document other than one sentence with the asterisk that said "However, a significant treatment * site interaction, opposite in sign with site of care was observed and, therefore, Wilks test was used to confirm changes in -2 log likelihood."

I am thinking that "a significant treatment site interaction" was probably death due to nosocomial infection, etc. If so, then all this does is establish even more credibility of the team by not allowing this to skew data in their favor.

Either way, if true counts are played, Aviptadil has a REALLY significant affect on probability of death (Avip=35.1% vs Placebo=56.9% at P<0.00181)...HUGE as we already know.

Just wanted everyone to feel comfortable with the 60 day results. Our team did not embellish...in reality they were extremely conservative in the reporting of their results.


(0)
(0)




Mondobiotech Holding AG Basel (RLFTF) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


$MJ




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us